3fq9: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''Unreleased structure'''
'''Unreleased structure'''


The entry 3fq9 is ON HOLD  
The entry 3fq9 is ON HOLD until Paper Publication


Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.
Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.
Line 7: Line 7:
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 20 16:33:04 2009''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul  1 08:53:56 2009''

Revision as of 08:53, 1 July 2009

Unreleased structure

The entry 3fq9 is ON HOLD until Paper Publication

Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.

Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications

Page seeded by OCA on Wed Jul 1 08:53:56 2009

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA